Welcome to the e-CCO Library!

P644: Leucine-rich alpha 2 glycoprotein- A useful biomarker to discriminate small intestinal mucosal healing in asymptomatic CRP-negative Crohn's disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Tanaka, A.(1)*;Kanmura, S.(1);Maeda, N.(1);Kuwazuru, K.(1);Komaki, F.(1);Komaki, Y.(1);Ido, A.(1);
Created: Friday, 14 July 2023, 11:12 AM
P644: Mindfulness-based stress reduction in adult patients with active Crohn's disease: preliminary findings based on the subjective units of distress scale: an IIRN study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

D. Schwartz*1, G. Goren2, P. Perpinial2, M. Friger3, O. Sarid2, V. Slonim-Nevo2, R. Sergienko3, A. Nemirovsky4, E. Vinogradov4, D. Greenberg6, A. Monsonego4, D. Turner7, A. Eliakim8, S. Ben Horin8, Y. Chowers9, H. Yanai10, I. Dotan10, S. Odes1

Created: Friday, 22 February 2019, 9:41 AM
P645 Adalimumab drug monitoring is superior to empirical treatment adjustment in inflammatory bowel disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

P. CURRAIS1, S. Fernandes2, S. Bernardo2, L. Correia2, A.R. Gonçalves2, C. Baldaia2, P. Moura Santos2, A. Valente2, R. Tato Marinho2

Created: Thursday, 30 January 2020, 10:12 AM
P645: Dynamics of proinflammatory cytokines in patients with Crohn's disease who received combined therapy with mesenchymal stromal cells of bone marrow and azathioprine
Year: 2018
Source: ECCO '18 Vienna
Authors:

O. Knyazev, N. Fadeeva*, A. Babayan, E. Dobroluybova, I. Donchenko

Created: Thursday, 21 February 2019, 9:14 AM
P645: Ileocecal resection in paediatric Crohn’s disease based on the Hungarian Paediatric IBD Registry
Year: 2022
Source: ECCO'22
Authors: Müller, K.(1,2);Bajzat, D.(1,3);László, S.S.(4); HUPIR Group
Created: Friday, 11 February 2022, 3:56 PM
P645: Mental health, work presenteeism and exercise in IBD patients
Year: 2021
Source: ECCO'21 Virtual
Authors: Sciberras, M.(1);Nascimento, C.(2);Tabone, T.(1);Karmiris, K.(3);Nikolaou, P.(3);Theodoropoulou, A.(3);Mula, A.(1);Goren, I.(4);Yanai, H.(4);Amir, H.(4);Mantzaris, G.(5);Georgiadi, T.(5);Foteinogiannopoulou, K.(6);Koutroubakis, I.(6);Allocca, M.(7);Fiorino, G.(7);Furfaro, F.(7);Katsanos, K.H.(8);Fousekis, F.(8);Michalopoulos, G.(9);Torres, J.(2);Ellul, P.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P645: Pharmacokinetics and immunogenicity of Infliximab biosimilar in inflammatory bowel disease patients
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

J. Guardiola*1,2, L. Rodriguez Alonso1, N. Padullés3, E. Santacana3, K. Serra1, A. Padulles3, A. Ruiz-Cerulla1, P. Gilabert1, C. Arajol1, G. Ibañez-Sanz1, B. Camps1, H. Colom2, J. Bas4, F. Morandeira4, E. Sanchez1, J. Orobitg1, F. Rodriguez Moranta1

Created: Friday, 22 February 2019, 9:41 AM
P645: The introduction of infliximab therapeutic drug level monitoring for is associated with cost savings in a cohort of patients in a large district general hospital
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Whiteoak S., Johnson H., Hovell C., Weaver S., McLaughlin S.

Created: Wednesday, 20 February 2019, 10:36 AM
P645: Use of Leukocytapheresis in inflammatory bowel disease in paediatric patients. A serie of 10 cases.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Martinez Navarro, G.(1)*;Palomino Pérez, L.M.(1);Velasco Rodríguez-Belvís, M.(1);Cañedo Villarroya, E.(1);De la Mano Hernández, A.(1);Dominguez Ortega, G.(1);Martínez Pérez, J.(1);Martín Fernández, C.(1);Di Campli Zaghlul, M.(1);García Hernández, P.(1);Sánchez Llorente, P.(1);Muñoz Codoceo, R.A.(1);
Created: Friday, 14 July 2023, 11:12 AM
P646 Utilisation of indocyanine green fluorescence imaging for Crohn’s disease following intestinal resection
Year: 2020
Source:

ECCO'20 Vienna

Authors:

Y. Duan, Y. Li

Created: Thursday, 30 January 2020, 10:12 AM
P646: Histological remission in patients with moderate-to-severe ulcerative colitis undergoing biological therapy: a single-centre experience
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Di Ruscio*1, A. Variola1, A. Geccherle1, G. Lunardi2, P. Castelli3, G. Zamboni3, R. Riddell4

Created: Friday, 22 February 2019, 9:41 AM
P646: Low FODMAPs diet as a magic bullet in reducing symptoms in different gastrointestinal diseases
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Testa A., Imperatore N., Rispo A., Capone P., Rea M., Nardone O.M., Opramolla A., Tortora R., Caporaso N., Castiglione F.

Created: Wednesday, 20 February 2019, 10:36 AM
P646: Refinement of surgical technique offsets increased severity of Crohn’s disease and co-morbidities to maintain low post-operative morbidity
Year: 2018
Source: ECCO '18 Vienna
Authors:

D. Mege1,2*, K. Garrett1, J. Milsom1, T. Sonoda1, F. Michelassi1

Created: Thursday, 21 February 2019, 9:14 AM
P646: The Loss of Productivity in Employment and Education Associated to Inflammatory Bowel Diseases: A Pilot Study of the Patient’s Perception
Year: 2021
Source: ECCO'21 Virtual
Authors: Nieves-Jimenez, H.(1);Solis-Pomales, C.(1);Ortiz-Domenech, S.(1);Marrero-Concepcion, F.(1);Marrero-Irizarry, J.(1);Torres, E.A.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P646: Will the screening of SARS-COV-2 infection in IBD infusion centers be useful?
Year: 2022
Source: ECCO'22
Authors: Abreu, N.(1);Oliveira, A.(1);Morna, H.(1);Jasmins, L.(1);
Created: Friday, 11 February 2022, 3:56 PM
P647 Post-marketing evaluation of reported adverse events of a multi-strain probiotic product confirms that change in manufacturing site had no impact on safety profile
Year: 2020
Source:

ECCO'20 Vienna

Authors:

V. Panetta1, I. Simonelli1, A. Bacchieri2, S. Papetti3, E. De Stefani3, S. Colombo4

Created: Thursday, 30 January 2020, 10:12 AM
P647: A pilot study: The importance of cognitive flexibility and flexibility in coping with stress for the quality of life in inflammatory bowel disease patients during biological therapy
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Rudnik*1,2, G. Piotrowicz2, M. Basińska3, G. Rydzewska4,5, V. Rashedi6,7

Created: Friday, 22 February 2019, 9:41 AM
P647: Awareness, knowledge and use of mesenchymal stem cells – a global survey among gastroenterologists and colorectal surgeons
Year: 2021
Source: ECCO'21 Virtual
Authors: Williams, P.(1);Klersy, C.(2);Karki, C.(3);Bennett, D.(3);Rodríguez, A.M.(4);Ciccocioppo, R.(5);
Created: Wednesday, 2 June 2021, 4:12 PM
P647: Idiopathic Thrombocytopenic Purpura associated with Inflammatory Bowel Disease: a multi-centre ECCO CONFER case series
Year: 2022
Source: ECCO'22
Authors: Mahajna , H.(1);Verstockt , B.(2);Bergemalm , D.(3);Castiglione , F.(4);Rodríguez-Moranta , F.(5);Vincenzo Savarino , E.(6);Hoentjen , F.(7,8);Bessissow , T.(9);Pokryszka , J.(10);Cremer , A.(11);Eder , P.(12);Truyens , M.(13);Yershalmy-Feler , A.(14);García , M.J.(15);Kopylov , U.(1);
Created: Friday, 11 February 2022, 3:56 PM